Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target (Q34978486)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target |
scientific article |
Statements
1 reference
Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target (English)
1 reference
Yang Liu
1 reference
David J Kwiatkowski
1 reference
27 October 2014
1 reference
1 reference
Identifiers
1 reference